This test detects the capsule antigen of Cryptococcus neoformans in serum and cerebrospinal fluid (CSF) using a commercial lateral flow test. Samples are initially screened at 1 in 2 and 1 in 100 dilutions. If either of these tests is positive, the sample can be titrated upon request.
This test is appropriate for the diagnosis of cryptococcosis. Note this test is appropriate for both immunocompetent and immunocompromised patients.
|Red top, black ring. Serum sample. CSF white topped universal.
|Positive results are highly likely to indicate cryptocococcosis
|LGI Microbiology Department
|300ul serum or CSF
|IP Routine TAT
|GP Routine TAT